1. Home
  2. NTRA vs GFL Comparison

NTRA vs GFL Comparison

Compare NTRA & GFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • GFL
  • Stock Information
  • Founded
  • NTRA 2003
  • GFL 2007
  • Country
  • NTRA United States
  • GFL Canada
  • Employees
  • NTRA N/A
  • GFL N/A
  • Industry
  • NTRA Medical Specialities
  • GFL
  • Sector
  • NTRA Health Care
  • GFL
  • Exchange
  • NTRA Nasdaq
  • GFL Nasdaq
  • Market Cap
  • NTRA 20.6B
  • GFL 18.1B
  • IPO Year
  • NTRA 2015
  • GFL 2020
  • Fundamental
  • Price
  • NTRA $161.01
  • GFL $44.83
  • Analyst Decision
  • NTRA Strong Buy
  • GFL Buy
  • Analyst Count
  • NTRA 15
  • GFL 10
  • Target Price
  • NTRA $152.67
  • GFL $45.80
  • AVG Volume (30 Days)
  • NTRA 1.2M
  • GFL 1.2M
  • Earning Date
  • NTRA 11-12-2024
  • GFL 02-18-2025
  • Dividend Yield
  • NTRA N/A
  • GFL 0.12%
  • EPS Growth
  • NTRA N/A
  • GFL N/A
  • EPS
  • NTRA N/A
  • GFL N/A
  • Revenue
  • NTRA $1,531,955,000.00
  • GFL $5,743,291,755.00
  • Revenue This Year
  • NTRA $53.71
  • GFL $5.50
  • Revenue Next Year
  • NTRA $11.00
  • GFL $6.52
  • P/E Ratio
  • NTRA N/A
  • GFL N/A
  • Revenue Growth
  • NTRA 54.94
  • GFL 4.09
  • 52 Week Low
  • NTRA $58.53
  • GFL $30.57
  • 52 Week High
  • NTRA $175.63
  • GFL $48.87
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 45.49
  • GFL 49.75
  • Support Level
  • NTRA $153.53
  • GFL $44.40
  • Resistance Level
  • NTRA $172.80
  • GFL $46.82
  • Average True Range (ATR)
  • NTRA 5.91
  • GFL 1.23
  • MACD
  • NTRA -2.98
  • GFL -0.29
  • Stochastic Oscillator
  • NTRA 8.17
  • GFL 15.44

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About GFL GFL Environmental Inc. Subordinate voting shares no par value

GFL Environmental Inc is an environmental services company. Its offerings include non-hazardous solid waste management, infrastructure, soil remediation, and liquid waste management services. Its solid waste management business line, which generates the majority of the revenue, consists of the collection, transportation, transfer, recycling, and disposal of non-hazardous solid waste. Its Environmental Services business line includes liquid waste and soil remediation. GFL's geographical segments are Canada and the United States. The company derives the majority of its revenue from the United States.

Share on Social Networks: